The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 Mar 2016 15:49

RNS Number : 0050R
Tungsten Corporation PLC
03 March 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Tungsten Corp Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Morgan Stanley

(Institutional Securities Group and Global Wealth Management)

4. Full name of shareholder(s)  (if different from 3.):iv

Morgan Stanley & Co. International plc

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

01.03.2016

6. Date on which issuer notified:

03.03.2016

7. Threshold(s) that is/are crossed orreached: vi, vii

8%

 

 

 

 

 

 

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

GB00B7Z0Q502

 

5,617,809

 

 

5,617,809

 

 

6,236,728

 

 

6,236,728

 

4.95%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

Right of Recall over a securities lending agreement

N/A

N/A

 

395,035

 

0.31%

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Equity Swap (Cash-Settled)

N/A

 

16/03/2016

 

N/A

 

 

3,500,000

 

 

Nominal

Delta

N/A

2.78%

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

10,131,763

 

 

8.04%

 

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA is a direct holder of

9,800,955 voting rights (7.77%) and is a subsidiary of Morgan Stanley Investments (UK)

 

Morgan Stanley Investments (UK), 20 Bank Street, Canary Wharf, London E14 4AD is an indirect holder of

9,800,955 voting rights (7.77%) and is a subsidiary of Morgan Stanley UK Group

 

Morgan Stanley UK Group, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of

9,800,955 voting rights (7.77%) and is a subsidiary of Morgan Stanley International Limited

 

Morgan Stanley International Limited, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of

9,800,955 voting rights (7.77%) and is a subsidiary of Morgan Stanley International Holdings Inc.

 

Morgan Stanley International Holdings Inc., c/o The Corporation Trust Company (DE), Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware 19801, USA is an indirect holder of 9,800,955 voting rights (7.77%) and is a subsidiary of the beneficial owner Morgan Stanley

 

Proxy Voting:

10. Name of

 the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

14. Contact name:

Craig Horsley

15. Contact telephone number:

0141 245 7736

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUGURCWUPQGAW
Date   Source Headline
15th Dec 20212:41 pmRNSStatement Re Possible Offer for Tungsten Corp
15th Dec 20212:35 pmEQSForm 8.3 - Maitland Institutional Services Limited: Form 8.3 (OPD) - Tungsten Corp Plc
15th Dec 20212:12 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Tungsten Corporation plc
15th Dec 20212:00 pmRNSForm 8.3 - Tungsten
15th Dec 20211:45 pmRNSForm 8.3
15th Dec 202112:13 pmBUSForm 8.3 - Tungsten Corporation plc
14th Dec 20215:35 pmRNSStatement re Possible Offer
14th Dec 20213:18 pmRNSStatement re Possible Offer
13th Dec 20217:01 amRNSInterim Results
13th Dec 20217:00 amRNSUS Litigation Settlement
7th Dec 20217:00 amRNSInvestor Presentation
3rd Dec 20217:00 amRNSPartnership Agreement
1st Dec 202111:27 amRNSHolding(s) in Company
30th Nov 202111:15 amRNSHolding(s) in Company
29th Nov 20214:41 pmRNSSecond Price Monitoring Extn
29th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSHolding(s) in Company
25th Nov 20217:00 amRNSHolding(s) in Company
23rd Nov 20213:02 pmRNSHolding(s) in Company
22nd Nov 20215:44 pmRNSHolding(s) in Company
22nd Nov 20217:00 amRNSHolding(s) in Company
4th Nov 20214:36 pmRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSCustomer Win
2nd Nov 20217:10 amRNSCustomer Contract Cancellation
15th Oct 20213:28 pmRNSResult of AGM
14th Oct 20214:36 pmRNSHolding(s) in Company
8th Oct 20214:41 pmRNSSecond Price Monitoring Extn
8th Oct 20214:36 pmRNSPrice Monitoring Extension
7th Oct 20214:41 pmRNSSecond Price Monitoring Extn
7th Oct 20214:36 pmRNSPrice Monitoring Extension
30th Sep 20217:07 amRNSISAE 3402 Accreditation
23rd Sep 20217:00 amRNSPosting of Report and Accounts and Notice of AGM
16th Sep 20215:03 pmRNSDirector Appointment
16th Sep 20218:40 amRNSSupply Chain Finance Partnership
27th Aug 20217:00 amRNSAdditional Listing and Total Voting Rights
23rd Aug 20217:00 amRNSDirector/PDMR Shareholdings
30th Jul 20217:00 amRNSFinal Results
15th Jun 20214:40 pmRNSSecond Price Monitoring Extn
15th Jun 20214:35 pmRNSPrice Monitoring Extension
14th Jun 20217:00 amRNSDirectorate Change
10th Jun 20214:40 pmRNSSecond Price Monitoring Extn
10th Jun 20214:35 pmRNSPrice Monitoring Extension
9th Jun 20217:00 amRNSChange of Chief Executive Officer
7th Jun 20217:00 amRNSCustomer Win
4th Jun 20217:00 amRNSTrading Update
20th May 20217:00 amRNSAppointment of Chief Financial Officer
20th Apr 20214:41 pmRNSSecond Price Monitoring Extn
20th Apr 20214:35 pmRNSPrice Monitoring Extension
13th Apr 20217:00 amRNSCustomer Win
30th Mar 202112:15 pmRNSAdditional Listing and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.